Biocure Technology Inc.

OTC: BICTF · Healthcare · Biotechnology

Canadian filerHQ Vancouver, BCReports USD

#1143 of 1,394 Healthcare companies by revenue

EA Score

——

FH 66DQ —GM —SS 24

v0.1 · 35/100 weight · pillars only

↑ balance-sheet leverage, return on assets · ↓ workforce scale, market scale

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$73.5k

Employees

Market cap

$379.1k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$00 CAD2025

Net income-$73.5k-102.8k CAD2025

Operating income-$64.9k-90.8k CAD2025

Total assets$1.5M2.0M CAD2025

Liabilities$317.1k434.7k CAD2025

Equity$1.1M1.6M CAD2025

Revenue trend

FY2018 – FY2025 · USD

FY18

FY19

FY20

FY21

FY22

FY23

FY24

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Biocure Technology Inc. booked $0 in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

ProPhase Labs, Inc.38D CuraScientific Corp——Actavia Life Sciences, Inc.——Longevity Health Holdings Inc.22D

Key facts

CEOYee Sing Cheng

SectorHealthcare

IndustryBiotechnology

HeadquartersVancouver, BC

ExchangeOTC: BICTF

Employees3

IPO date2018-11-28

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.